Results 21 to 30 of about 420,257 (333)
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Cells, 2022 Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the main cause of vision impairment in diabetic patients, with its pathogenesis ...
Jingfa Zhang +6 more
semanticscholar +1 more source
International Journal of Molecular Sciences, 2022 Diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) are common retinal vascular diseases responsible for most blindness in the working-age and older population in developed countries.
Sławomir Liberski +2 more
semanticscholar +1 more source
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
New England Journal of Medicine, 2022 BACKGROUND In eyes with diabetic macular edema, the relative efficacy of administering aflibercept monotherapy as compared with bevacizumab first with a switch to aflibercept if the eye condition does not improve sufficiently (a form of step therapy) is ...
Chirag D. Jhaveri +15 more
semanticscholar +1 more source
Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Current Diabetes Reports, 2021 Purpose of Review This review highlights indications and evidence on laser therapy in the management of diabetic retinopathy and diabetic macular edema.
Lesley A. Everett, Y. Paulus
semanticscholar +1 more source
Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema
International Journal of Molecular Sciences, 2021 Diabetic macular edema (DME) is a critical complication of diabetic retinopathy, a condition that arises from the breakdown of the blood–retinal barrier and the consequent increase in vascular permeability.
H. Noma, K. Yasuda, M. Shimura
semanticscholar +1 more source
Journal of Medical Case Reports, 2021 Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane family of anticancer agents. There is no established treatment or standard treatment protocol for taxane-related cystoid macular edema.
Mitsuru Otsubo +3 more
doaj +1 more source
Revista de la Facultad de Medicina, 2022 Introducción: La tomografía de coherencia óptica y la angiografía con fluoresceína son estudios de imagen oftalmológicas de gran utilidad para el diagnóstico de edema macular diabético.
María Alejandra Carías Morales +1 more
doaj +1 more source
Intravitreal Therapy for Diabetic Macular Edema: An Update
Journal of Ophthalmology, 2021 Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight-threatening condition, it is also among the most accessible to treatment.
C. Furino +3 more
semanticscholar +1 more source
Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review
BMC Neurology, 2023 Background As a modulator of the sphingosine 1-phosphate receptor, siponimod is administered as a therapeutic intervention for multiple sclerosis. A previous phase 3 study first reported siponimod-associated macular edema.
Qingsheng Li +3 more
doaj +1 more source
Development of Clinical and Morphometric Classification of Macular Edema in Retinal Vein Occlusions
Oftalʹmologiâ, 2022 Purpose. To study the morphometric features of macular edema in occlusions of the retinal veins, to determine and systematize the conditional gradations of the degrees of its severity.Patients and methods.
A. A. Fil, E. L. Sorokin, O. V. Kolenko
doaj +1 more source